Eaton Vance Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.74M Buy
2022
Q2
$2.41M Sell
2022
Q1
$2.88M Buy
2021
Q4
$1.06M Sell
2021
Q3
$1.62M Buy
2021
Q2
$3.11M Buy
2021
Q1
$1.85M Buy
2020
Q4
$2.42M Sell
2020
Q3
$1.56M Hold
2020
Q2
$831K Hold
2020
Q1
$944K Hold
2019
Q4
$1.18M Hold
2019
Q3
$1.05M Buy